Koppel Adam 4
4 · Cerevel Therapeutics Holdings, Inc. · Filed Jun 16, 2022
Insider Transaction Report
Form 4
Koppel Adam
Director10% Owner
Transactions
- Award
Stock Option (Right to Buy)
2022-06-14+23,459→ 23,459 totalExercise: $24.35Exp: 2032-06-14→ Common Stock (23,459 underlying)
Footnotes (1)
- [F1]100% of the shares subject to this option shall vest and become exercisable on the earlier of: (i) the one year anniversary of the Grant Date, or (ii) the next annual meeting of stockholders of the Company occurring after the Grant Date.